Auswahl unserer wichtigsten Publikationen

Publikationen

Rohmann N, Schlicht K, Corinna G, Hollstein T, Knappe C, Krause L, Hagen S, Beckmann A, Seoudy AK, Wietzke-Braun P, Hartmann K, Schulte D, Türk K, Beckmann J, von Schönfels W, Hägele FA, Bosy-Westphal A, Franke A, Schreiber S, Laudes M. „Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation.“ Journal of Clinical Endocrinology and Metabolism. 2020 Oct 21:dgaa758. doi: 10.1210/clinem/dgaa758. (IF 5.6)

Hollstein T, Schulte DM, Schulz J, Glück A, Ziegler AG, Bonifacio E, Wendorff M, Franke A, Schreiber S, Bornstein SR, Laudes M. „Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report.“ Nature Metabolism. 2020 Sep 2. doi: 10.1038/s42255-020-00281-8. Online ahead of print.

Schlicht K, Rohmann N, Geisler C, Hollstein T, Knappe C, Hartmann K, Schwarz J, Tran F, Schunk D, Junker R, Bahmer T, Rosenstiel P, Schulte D, Türk K, Franke A, Schreiber S, Laudes M. „Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections.“ 2020 International Journal of Obesity (IF 5,3). Sep 21. doi: 10.1038/s41366-020-00689-y. Online ahead of print

Fangmann, D., Geisler, C. , Schlicht, K., Hartmann, K., Köpke, J., Tiede, A., Settgast, U., Türk, K., Schulte, D.M., Altmann, K., Clawin-Rädecker, I., Lorenzen, P.C., Schreiber, S., Schwarz, K., Laudes, M. „Differential effects of protein intake versus intake of a defined oligopeptide on FGF-21 in obese human subjects in vivo“ (2020), Clinical Nutrition, Jun 17:S0261-5614(20)30296-X(IF 6.4)

van Dam, E., van Leeuwen, L.A.G., Dos Santos, E., James, J., Best, L., Lennicke, C., Vincent, A.J., Marinos, G., Foley, A., Buricova, M., Mokochinski, J.B., Kramer, H.B., Lieb, W., Laudes, M., Franke, A., Kaleta, C., Cochemé, H.M. „Sugar-Induced Obesity and Insulin Resistance Are Uncoupled from Shortened Survival in Drosophila“ (2020), Cell Metabolism 31:710-725.e7 (IF 22.4)

Pryor, R., Norvaisas, P., Marinos, G., Best, L., Thingholm, L. B., Quintaneiro, L., De Haes, W., Esser, D., Waschina, S., Lujan, C., Smith, R. L., Scott, T., Martinez-Martinez, D., Woodward, O., Bryson, K., Laudes, M., Lieb, W., Houtkooper, R. H., Franke, A., Temmerman, L., Bjedov, I., Cochemé, H. M., Kaleta, C., Cabreiro, F. “Metformin prolongs host lifespan through bacterial nutrient signaling pathways in the gut microbiome” (2019), Cell 178:1299-1312 (IF 36,2)

Laudes, M., Frohnert, J., Ivanova, K., Wandinger, K. P.: „PTH immunoassay interference due to human anti-mouse antibodies in an obese subject with normal parathyroid function”, (2019) Journal of Clinical Endocrinology and Metabolism, 104:5840-5842 (IF 5.8)

Thingholm, L. B., Rühlemann, M. C., Koch, M., Fuqua, B., Laucke, G., Boehm, R., Bang, C., Franzosa, E. A., Hübenthal, M., Rahnavard, A., Frost, F., Lloyd-Price, J., Schirmer, M., Lusis, A.J., Vulpe, C.D., Lerch, M. M., Homuth, G., Kacprowski, T., Schmidt, C.O., Nöthlings, U., Karlsen, T.H., Lieb, W., Laudes, M., Franke, A., Huttenhower, C. „Obese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition” (2019), Cell Host & Microbe 26, 1–13 (IF 17,9)

Fangmann, D., Theismann, E.M., Türk, K., Schulte, D.M., Relling, I., Hartmann, K., Keppler, J.K., Knipp, J.R., Rehman, A., Heinsen, F.A., Franke, A., Lenk, L., Freitag-Wolf, S., Appel, E., Gorb, S., Brenner, C., Seegert, D., Waetzig, G.H., Rosenstiel, P., Schreiber, S., Schwarz, K., Laudes, M. “Targeted microbiome intervention by microencapsulated delayed-release niacin beneficially affects insulin sensitivity in humans” (2018), Diabetes Care, 41:398-405 (IF 13,4)

Relling, I., Akcay, G., Fangmann, D., Knappe, C., Schulte, D.M., Hartmann, K., Müller, N., Türk, K., Dempfle, A., Franke, A., Schreiber, S., Laudes, M. „Role of wnt5a in metabolic inflammation in humans“ (2018), Journal of Clinical Endocrinology and Metabolism, 103:4253-4264 (IF 5,8)

Kreutzer, C., Peters, S., Schulte, D.M., Fangmann, D., Türk, K., Wolf, S., van Eimeren, T., Ahrens, M., Beckmann, J., Schafmeyer, C., Kerby, T., Rohr, A., Riedel, C., Heinsen, F.A., Degenhardt, F., Franke, A., Rosenstiel, P., Henning, C., Freitag-Wolf, S., Dempfle, A., Jansen, O., Schreiber, S., Laudes, M.: “Hypothalamic inflammation in human obesity is mediated by environmental and genetic factors”, (2017) Diabetes, 66:2407-2415 (IF 8.8)

Wang, J., Thingholm, L. B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J. R., Degenhardt, F., Heinsen, F. A., Rühlemann, M. C. , Szymczak, S. , Holm, K., Esko, T. , Sun, J. , Pricop-Jeckstadt, M. , Al-Dury, S. , Bohov, P. , Bethune, J., Sommer, F., Ellinghaus, D., Berge, R. K. , Hübenthal, M. , Koch, M. , Schwarz, K., Rimbach, G., Hüppe, P., Pan, W. H., Sheibani-Tezerji, R., Häsler, R., Rosenstiel, P., D’Amato, M., Cloppenborg-Schmidt, K., Künzel, S. , Laudes, M., Marschall, H. U. , Lieb, W. , Nöthlings, U. , Karlsen, T. H. , Baines, J. F., Franke., A.: “Genome-wide host-microbiota association analysis of 1,812 individuals identifies vitamin D receptor genetic variation and other host factors shaping the gut microbiota” (2016), Nature Genetics, 48:1396-1406 (IF 29.3)

Müller, N., Schulte, D. M., Türk, K., Freitag-Wolf, S., Hampe, J., Rose-John, S., Zeuner, R., Schröder, J. O., Gouni-Berthold, I., Berthold, H., Krone, W., Schreiber, S., Laudes, M.: „IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans“, (2015), Journal of Lipid Research, 56:1034-1042 (IF 4.8)

Bilkovski, R., Oberhauser, F., Droste, A., Schulte, D. M., Gomolka, M., Udelhoven M., Hettich M., Roth, B., Heidenreich, A., Gutschow, C., Krone, W., Laudes, M.: “Role of wnt-5a in the determination of human mesenchymal stem cells into preadipocytes” (2010) Journal of Biological Chemistry, 285:6170-6178 (IF 5.3)

Laudes, M., Barroso, I., Luan, J., Soos, M.A., Yeo, G., Meirhaeghe, A., Logie, L., Vidal-Puig, A., Schafer, A., Wareham, N.J., O´Rahilly, S.: “Genetic variants in human Sterol Regulatory Element Binding Protein (SREBP)-1c in syndromes of severe insulin resistance and type 2 diabetes”, (2004) Diabetes,  53: 842-846 (IF 8.5)